Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago, Illinois.
OBJECTIVE
Rehospitalization after a diabetes diagnosis in youth signals the failure of outpatient management. We examined risk factors for rehospitalization among young patients with diabetes.


METHODS
We queried 535 participants diagnosed before 18 years of age from the Chicago Childhood Diabetes Registry. Demographic, social, and clinical data were used in logistic models of diabetes-related rehospitalization, as well as, among those rehospitalized, frequent (> or = once per 2 years' duration) versus infrequent rehospitalization rates.


RESULTS
Mean (range) duration was 5.1 years (0.1-19.2 years). The sample was 55% non-Hispanic black, 11% non-Hispanic white, 26% Hispanic, and 7% other/mixed race; 86% had presumed type 1 diabetes; and 47% were underinsured. Overall, 46% reported rehospitalization for diabetes. In multivariable logistic regression, ever being rehospitalized was significantly associated with diabetes duration (per year, odds ratio [OR]: 1.26; P < .01), female gender (OR: 1.67; P = .01), underinsurance (versus private insurance; OR: 1.79; P < .01), presumed phenotype (non-type 1 diabetes versus type 1; OR: 0.32; P < .01), and diagnosis at a community hospital (versus tertiary care facility; OR: 1.96; P < .01) and tended to be higher for those of nonwhite race (OR: 1.94; P = .07). Among those rehospitalized, multivariable associations with frequent rehospitalization were presumed phenotype (non-type 1 diabetes versus type 1; OR: 2.74; P = .04), head of household not working (versus employed; OR: 1.88; P = .02), and younger age at questionnaire (per year; OR: 0.94; P = .01).


CONCLUSIONS
Rehospitalization is common in young patients with diabetes, especially for those with limited resources, indicating the need for improved outpatient services. Comprehensive initial education and support available to young patients with diabetes diagnosed at tertiary care facilities and their families may have lasting protective effects.
Estrada
Carmela L
CL
Institute for Endocrine Discovery and Clinical Care, University of Chicago, Chicago, Illinois, USA.
Danielson
Kirstie K
KK
Drum
Melinda L
ML
Lipton
Rebecca B
RB
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000628:therapy*; D005260:Female; D006801:Humans; D007087:Illinois; D008297:Male; D010359:Patient Readmission / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D012307:Risk Factors; D055815:Young Adult
Diabet Med. 2007 Apr;24(4):440-2
17367308
Diabetes Care. 2007 Dec;30(12):3035-9
17728482
Am J Epidemiol. 1997 Oct 15;146(8):627-36
9345116
Diabetes Care. 2005 Sep;28(9):2150-4
16123482
Diabetes Care. 1999 Feb;22(2):345-54
10333956
Lancet. 2007 May 26;369(9575):1823-1831
17531891
J Pediatr. 2007 Mar;150(3):279-85
17307546
J Clin Endocrinol Metab. 2003 Apr;88(4):1417-27
12679416
Pediatrics. 2006 Aug;118(2):577-85
16882810
Pediatr Diabetes. 2002 Mar;3(1):16-22
15016170
BMC Health Serv Res. 2007 Dec 05;7:199
18053255
J Pediatr Endocrinol Metab. 2008 Apr;21(4):349-58
18556966
Diabetes Care. 1997 Nov;20(11):1677-82
9353607
Arch Pediatr Adolesc Med. 2003 Sep;157(9):919-25
12963599
N Engl J Med. 1993 Sep 30;329(14):977-86
8366922
Diabetologia. 2001 Oct;44 Suppl 3:B87-92
11724423
J Pediatr Endocrinol Metab. 2007 Oct;20(10):1093-107
18051928
Pediatrics. 2006 Oct;118(4):1510-8
17015542
Pediatrics. 2008 Apr;121(4):e912-9
18381520
J Diabetes Complications. 2000 Mar-Apr;14(2):71-7
10959068
Arch Intern Med. 1999 Sep 27;159(17):2053-7
10510991
Diabetes Care. 2003 May;26(5):1421-6
12716799
JAMA. 2002 May 15;287(19):2511-8
12020331
Pediatrics. 2004 Mar;113(3 Pt 1):496-504
14993540
Arch Pediatr Adolesc Med. 2008 Jul;162(7):649-57
18606936
Am J Epidemiol. 1996 Mar 1;143(5):431-41
8610658
Diabetes Care. 2002 Sep;25(9):1584-90
12196431